THE NEED FOR CONTINUOUS USE OF ANTI-PARKINSONIAN MEDICATION WITH CHRONIC-SCHIZOPHRENIC PATIENTS RECEIVING LONG-TERM NEUROLEPTIC THERAPY

被引:0
作者
MANOS, N
GKIOUZEPAS, J
LOGOTHETIS, J
机构
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:184 / 188
页数:5
相关论文
共 20 条
[1]  
Aquilonius S, 1976, Lakartidningen, V73, P511
[2]  
CAROLI F, 1975, Encephale, V1, P69
[3]   ANTIPARKINSONIAN AGENTS AND DEPOT PHENOTHIAZINE [J].
CHIEN, CP ;
DIMASCIO, A ;
COLE, JO .
AMERICAN JOURNAL OF PSYCHIATRY, 1974, 131 (01) :86-90
[4]  
DiMascio A, 1970, Psychosomatics, V11, P596
[5]  
DIMASCIO A, 1971, DRUG THER, V1, P23
[6]  
Dolezalova B, 1975, Cesk Psychiatr, V71, P398
[7]  
FANN WE, 1975, DIS NERV SYST, V36, P91
[8]   OPEN WITHDRAWAL OF ANTIPARKINSON DRUGS IN NEUROLEPTIC-INDUCED PARKINSON SYNDROME [J].
FLEISCHHAUER, J .
INTERNATIONAL PHARMACOPSYCHIATRY, 1975, 10 (04) :222-229
[9]  
HUTTENBACH DE, 1977, AM J PSYCHIAT, V134, P820
[10]  
KLETT CJ, 1972, ARCH GEN PSYCHIAT, V26, P374